Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration in the Age-Related Eye Disease Study 2 (AREDS2)

被引：0
|
作者：
Nicholson, Benjamin [1 ]
Huynh, Nancy [2 ]
Agron, Elvira [1 ]
Clemons, Traci [3 ]
Chew, Emily [1 ]
机构：
[1] NEI, Epidemol & Clin Applicat, Bethesda, MD 20892 USA
[2] NEI, Ophthalm Clin Genet, Bethesda, MD 20892 USA
[3] EMMES Corp, Rockville, MD USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2013年 / 54卷 / 15期
关键词：
412 age-related macular degeneration; 445; cataract; 413; aging;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
243
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Visual acuity results at ten years in participants with age-related macular degeneration enrolled in the Age-Related Eye Disease Study 2
    Bhandari, Sanjeeb
    Konstantinou, Eleni
    Agron, Elvira
    Clemons, Traci E.
    Chew, Emily Y.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [22] Visual acuity outcomes in eyes treated with anti-VEGF injections during the Age-Related Eye Disease Study 2 (AREDS2)
    Vitale, Susan
    Agron, Elvira
    Keenan, Tiarnan
    Clemons, Traci E.
    Chew, Emily Y.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [23] Visual outcomes following cataract surgery in age-related macular degeneration patients
    Chen, Andrew X.
    Haueisen, Alexander
    Rasendran, Chandruganesh
    Hom, Grant L.
    Conti, Thais F.
    Conti, Felipe F.
    Greenlee, Tyler E.
    Briskin, Isaac N.
    Bena, James F.
    Singh, Rishi P.
    Talcott, Katherine E.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2021, 56 (06): : 348 - 354
  • [24] Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS)
    Martin, DF
    Bressler, NM
    Bressler, SB
    Chew, EY
    Clemons, TE
    Klein, R
    Seddon, JM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U109 - U109
  • [25] Progression of Geographic Atrophy in the Age-Related Eye Disease Study 2 (AREDS2)
    Chew, Emily Y.
    Agron, Elvira
    Clemons, Traci E.
    Domalpally, Amitha
    Danis, Ronald P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [26] The Association of Calcium Intake with Incidence of Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS)
    Tisdale, Alanna Kira
    Agron, Elvira
    Sunshine, Sarah B.
    Clemons, Traci E.
    Ferris, Frederick
    Chew, Emily Y.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [27] Lutein plus Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial
    Chew, Emily Y.
    Clemons, Traci E.
    SanGiovanni, John Paul
    Danis, Ronald
    Ferris, Frederick L., III
    Elman, Michael
    Antoszyk, Andrew
    Ruby, Alan
    Orth, David
    Bressler, Susan
    Fish, Gary
    Hubbard, Baker
    Klein, Michael
    Chandra, Suresh
    Blodi, Barbara
    Domalpally, Amitha
    Friberg, Thomas
    Wong, Wai
    Rosenfeld, Philip
    Agron, Elvira
    Toth, Cynthia
    Bernstein, Paul
    Sperduto, Robert
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (19): : 2005 - 2015
  • [28] Principal Cause of Poor Visual Acuity after Neovascular Age-Related Macular Degeneration Age-Related Eye Disease Study 2 Report Number 23
    Okeagu, Chinwenwa U.
    Agron, Elvira
    Vitale, Susan
    Domalpally, Amitha
    Chew, Emily Y.
    Keenan, Tiarnan D. L.
    OPHTHALMOLOGY RETINA, 2021, 5 (01): : 23 - 31
  • [29] Lutein/Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration. The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial
    Sadda, Srinivas
    OPHTHALMOLOGICA, 2013, 230 : 10 - 11
  • [30] The age-related eye disease study severity scale for age-related macular degeneration - AREDS report no. 17
    Davis, MD
    Gangnon, RE
    Lee, LY
    Hubbard, LD
    Klein, BEK
    Klein, R
    Ferris, FL
    Bressler, SB
    Milton, RC
    ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (11) : 1484 - 1498
12345